Kelly Shi
Stock Analyst at Jefferies
(3.13)
# 1,291
Out of 5,182 analysts
35
Total ratings
47.06%
Success rate
14.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Assumes: Buy | $252 → $290 | $241.71 | +19.98% | 3 | Mar 16, 2026 | |
| IBRX ImmunityBio | Maintains: Buy | $8 → $9 | $7.78 | +15.68% | 2 | Dec 12, 2025 | |
| KYMR Kymera Therapeutics | Maintains: Buy | $73 → $122 | $89.00 | +37.08% | 2 | Dec 9, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $63 → $77 | $73.52 | +4.73% | 4 | Oct 28, 2025 | |
| INSM Insmed | Maintains: Buy | $129 → $148 | $146.74 | +0.86% | 2 | Aug 13, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $23 → $28 | $36.32 | -22.91% | 1 | Jul 7, 2025 | |
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $21.12 | +108.33% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $6.33 | +136.97% | 1 | Apr 10, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $8.89 | +484.93% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.87 | +187.47% | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $19 | $39.61 | -52.03% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $9.10 | +130.77% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $24.33 | +52.08% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $6 | $2.01 | +198.51% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $97.10 | -16.58% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $29.41 | +19.01% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.40 | +958.82% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $18.02 | -11.21% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $18.23 | +9.71% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $432 | $7.92 | +5,354.55% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $15.41 | +237.44% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $2.93 | +821.50% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $3.82 | +763.87% | 1 | Mar 8, 2021 |
Ascendis Pharma
Mar 16, 2026
Assumes: Buy
Price Target: $252 → $290
Current: $241.71
Upside: +19.98%
ImmunityBio
Dec 12, 2025
Maintains: Buy
Price Target: $8 → $9
Current: $7.78
Upside: +15.68%
Kymera Therapeutics
Dec 9, 2025
Maintains: Buy
Price Target: $73 → $122
Current: $89.00
Upside: +37.08%
PTC Therapeutics
Oct 28, 2025
Maintains: Buy
Price Target: $63 → $77
Current: $73.52
Upside: +4.73%
Insmed
Aug 13, 2025
Maintains: Buy
Price Target: $129 → $148
Current: $146.74
Upside: +0.86%
Cogent Biosciences
Jul 7, 2025
Maintains: Buy
Price Target: $23 → $28
Current: $36.32
Upside: -22.91%
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $21.12
Upside: +108.33%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $6.33
Upside: +136.97%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $8.89
Upside: +484.93%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.87
Upside: +187.47%
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $39.61
Upside: -52.03%
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $9.10
Upside: +130.77%
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $24.33
Upside: +52.08%
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.01
Upside: +198.51%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $97.10
Upside: -16.58%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $29.41
Upside: +19.01%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $3.40
Upside: +958.82%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $18.02
Upside: -11.21%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $18.23
Upside: +9.71%
Mar 4, 2022
Initiates: Buy
Price Target: $432
Current: $7.92
Upside: +5,354.55%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $15.41
Upside: +237.44%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $2.93
Upside: +821.50%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $3.82
Upside: +763.87%